Kang Kristopher T, Potts James E, Radbill Andrew E, La Page Martin J, Papagiannis John, Garnreiter Jason M, Kubus Petr, Kantoch Michal J, Von Bergen Nicholas H, Fournier Anne, Côté Jean-Marc, Paul Thomas, Anderson Charles C, Cannon Bryan C, Miyake Christina Y, Blaufox Andrew D, Etheridge Susan P, Sanatani Shubhayan
Department of Pediatrics, Division of Cardiology, British Columbia Children's Hospital, Vancouver, BC, Canada.
Vanderbilt University Medical Center, Nashville, Tennessee.
Heart Rhythm. 2014 Aug;11(8):1426-32. doi: 10.1016/j.hrthm.2014.04.033. Epub 2014 Apr 24.
Permanent junctional reciprocating tachycardia (PJRT) is an uncommon form of supraventricular tachycardia in children. Treatment of this arrhythmia has been considered difficult because of a high medication failure rate and risk of cardiomyopathy. Outcomes in the current era of interventional treatment with catheter ablation have not been published.
To describe the presentation and clinical course of PJRT in children.
This is a retrospective review of 194 pediatric patients with PJRT managed at 11 institutions between January 2000 and December 2010.
The median age at diagnosis was 3.2 months, including 110 infants (57%; aged <1 year). PJRT was incessant in 47%. The ratio of RP interval to cycle length was higher with incessant than with nonincessant tachycardia. Tachycardia-induced cardiomyopathy was observed in 18%. Antiarrhythmic medications were used for initial management in 76%, while catheter ablation was used initially in only 10%. Medications achieved complete resolution in 23% with clinical benefit in an additional 47%. Overall, 140 patients underwent 175 catheter ablation procedures with a success rate of 90%. There were complications in 9% with no major complications reported. Patients were followed for a median of 45.1 months. Regardless of treatment modality, normal sinus rhythm was present in 90% at last follow-up. Spontaneous resolution occurred in 12% of the patients.
PJRT in children is frequently incessant at the time of diagnosis and may be associated with tachycardia-induced cardiomyopathy. Antiarrhythmic medications result in complete control in few patients. Catheter ablation is effective, and serious complications are rare.
永久性交界性反复性心动过速(PJRT)是儿童室上性心动过速的一种罕见形式。由于药物治疗失败率高和存在心肌病风险,这种心律失常的治疗一直被认为具有挑战性。目前导管消融介入治疗时代的治疗结果尚未见报道。
描述儿童PJRT的临床表现和临床过程。
这是一项对2000年1月至2010年12月期间在11家机构接受治疗的194例儿童PJRT患者的回顾性研究。
诊断时的中位年龄为3.2个月,其中110例为婴儿(57%;年龄<1岁)。47%的患者心动过速持续不停。持续性心动过速的RP间期与心动周期长度之比高于非持续性心动过速。18%的患者观察到心动过速性心肌病。76%的患者最初采用抗心律失常药物治疗,而最初仅10%的患者采用导管消融治疗。药物治疗使23%的患者完全缓解,另有47%的患者有临床获益。总体而言,140例患者接受了175次导管消融手术,成功率为90%。9%的患者出现并发症,未报告重大并发症。患者的中位随访时间为45.1个月。无论治疗方式如何,末次随访时90%的患者存在正常窦性心律。12%的患者出现自发缓解。
儿童PJRT在诊断时通常为持续性,可能与心动过速性心肌病有关。抗心律失常药物仅能使少数患者得到完全控制。导管消融有效,严重并发症罕见。